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The  majority  of adult  B  lymphocytes in  the  mouse  bear  two  immunoglobulin 
isotypes, IgM and IgD (#÷~+ cells) (1). A small population of IgM-bearing cells lacks, 
or expresses  very low  levels of IgD  U-predominant  [,up] cells)  (1).  These cells  are 
believed to constitute a less mature subset of B cells analogous to neonatal B cells (2). 
Based on the time during ontogeny when responses to T-independent  (TI)  and T- 
dependent (TD) antigens appear (3, 4) and the ability to block in vitro responses with 
anti-/.t or anti-8 (5, 6, D. Mosier, personal communication), it has been suggested that 
the precursors of two TI-1 responses, trinitrophenyl (TNP)-Brucella (TNP-BA) and 
TNP-lipopolysaccharide (TNP-LPS) are pp cells (5, 6), whereas the precursor for a 
TD response, TNP-sheep erythrocytes (TNP-SRBC), bears both IgM  and  IgD  (6). 
However, the possibility cannot be excluded that IgD is present on some or all of the 
TI precursors, but that it is not obligatory for triggering. 
In  the  present  experiments  we  have  examined  the  phenotypes  of TI  and  TD 
precursors by treating cells with C' and either anti-~ or anti-6 before stimulation with 
antigen.  Our results suggest  that  the majority of B  cells that  respond to TNP-BA, 
TNP-LPS, and TNP-SRBC bear IgD, even though in the case of the two TI antigens, 
IgD is not required for triggering. 
Materials and Methods 
Animals.  C57BL/6 (B6), BALB/c, and (C57BL/6 X  DBA/2)F1  (BDF1) female mice, 2-4 
mo of age, were obtained from The Jackson Laboratory, Bar Harbor, Maine. 
Antisera.  Anti-Ig5 b (alloanti-8) was obtained from Sera-Labs, Crawley Down, Sussex, Eng- 
land, and is the product of a hybridoma (H6/31.HLK) (7). Rabbit anti-mouse 8 (RAS) (1), 
rabbit  anti-mouse-//. (RA/~) (8), rabbit  anti-mouse  Ig  (RAMIg)  (8), and  rabbit  anti-TNP- 
ovalbumin (RA-TNP) (9) were prepared and assayed as described previously. 
Specificity of the Alloanti-~.  NP-40  lysates of radioiodinated splenocytes  were  prepared as 
described  previously  (8). The alloanti-6,  RAMIg,  and  RA-TNP  (control)  were  coupled  tO 
Sepharose  and added to aliquots of the cell lysate. After incubation at  37°C and 4°C,  the 
Sepharose  was  removed  by  centrifugation  and  the  supernates  treated  with  RAMIg  and 
Staphylococcus aureus. Complexes were eluted, reduced, and analyzed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis  (SDS-PAGE) (8). 
Deletion of B-Cell Subsets.  Complement-mediated cytolysis after treatment with each antise- 
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rum was performed as described  previously (10).  For killing with  anti-8 serum and  for cells 
cultured in vitro, sodium azide was not used. 
In  Vitro Response aJ~er Negative Selection.  Aliquots of 106 viable cells in  Richter's improved 
minimal essential medium with zinc and  insulin  (IMEMZO)  (Associated Biomedie Systems, 
Inc., Buffalo, N. Y.) with supplements (11) were plated in replicate (10 per sample) in microtiter 
dishes (Microtest II, Falcon Labware, Div. of Becton, Dickinson, Oxnard, & Co. Calif.)  (final 
vol: 0.2 ml per well) with TNP-SRBC (12) or TNP-BA (11). To each well containing TNP-BA 
was added  1.6  ×  l0  s irradiated (1,500  rads) splenocytes from unprimed B6 mice. Preliminary 
experiments established  that  the TNP-BA response is TI under  these conditions.  Each well 
containing TNP-SRBC received 1.6 ×  106 irradiated splenoeytes from mice primed with SRBC 
(11) as a source of T-helper cells (13). After 4 d  in culture  (14), cells in individual wells were 
washed  and  assayed  for  the  presence  of direct  plaque-forming  cells  (PFC)  to  TNP-horse 
erythrocytes (Colorado Serum Co., Denver, Colo.) (TNP-HRBC) (15-17). Percent inhibition of 
response was calculated on the basis of the number of input cells before depletion. 
In  Vivo Response after Negative Selection.  After  complement-mediated  cytolysis,  cells  were 
washed and 0.2 ml injected into syngeneic low dose primed (13) (for the TNP-SRBC response), 
irradiated recipients. Four animals per group were used. The extent of inhibition of the response 
was assessed by comparing the response of treated cells with the average response of two doses 
of control cells.  The lower dose was equivalent  to the number of experimental cells injected 
whereas the higher dose was equivalent  to the starting number of experimental  cells before 
eytolysis. The number of cells used was the minimum required to attain a linear dose-response 
curve. 24 h after reconstitution, the animals were challenged with 0.2  ml  10% TNP-SRBC or 
50  #g  TNP-LPS  (18,  19)  (LPS  from  Escherichia coli 055B5  [Difco  Laboratories,  Detroit, 
Mich.]). 5 d later, the animals were sacrificed and total PFC in the spleens against TNP-HRBC, 
HRBC, and SRBC were determined. 
Results 
Specificity  of the Alloanti-8 Serum.  The alloanti-8  serum  used  in these studies  is the 
product of the hybridoma H6/31.HLK  (7). The findings of Pearson et al. (7) indicate 
that this serum is specific for an allotypic determinant on &chains of mice bearing the 
Ig  b allele.  It  has  not  been  proven,  however,  that  this  alloanti-8  serum  is  devoid  of 
cross-reactivity  for  /~-chains,  i.e.,  it  could  have  specificity  against  a  determinant 
common  to  both  /~-  and  8-chains.  We  therefore  tested  this  possibility  by  treating 
aliquots  of lysate from iodinated  B6 spleen cells with Sepharose coupled to RAMIg, 
alloanti-8  or RA-TNP  (control).  The Sepharose was removed by centrifugation  and 
the  Ig remaining  in  each sample was precipitated  under  saturating  conditions  with 
RAMIg  and  S.  aureus, solubilized,  and  analyzed  by  SDS-PAGE.  Pretreatment  of 
lysates with  Sepharose  bound  to RAMIg  resulted  in  the  loss of both  IgM and  IgD 
(Fig.  1).  When  lysates  were  treated  with  Sepharose  bound  to  alloanti-~,  however, 
virtually  all  of  the  IgM,  but  less  than  15%  of  the  IgD  was  recovered  from  the 
supernate. Thus, there was no evidence for the binding of IgM by Sepharose alloanti- 
and it was concluded,  therefore,  that the alloanti-8 serum was specific for g-chains. 
The  specificity  of alloanti-8  was  further  examined  by  assessing  the  C'-mediated 
cytolytic  activity  of the  serum  against  spleen  cells  from  mice  carrying  Ig  b and  Ig  a 
alleles. As shown in Fig. 2, at optimal dilutions,  alloanti-~ killed approximately one- 
half of B6, but not BALB/c, spleen cells, thus confirming  (7)  the aUoreactivity of the 
serum. 
Effect of Deleting Cells Bearing IgM or IgD on the In  Vitro Response.  As shown in Table 
I, depletion of cells bearing either IgM or IgD resulted in a profound inhibition of the 
in  vitro  responses  to both  TNP-BA  and  TNP-SRBC.  In  two  of three  experiments, 
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Fro.  1.  Effect of treating lysates from radioiodinated C57BL/6 splenocytes with Sepharose coupled 
to RAMIg, RA-TNP-ovalbumin, or alloanti-8 on the subsequent recovery oflgM and IgD. Aliquots 
of lysate from radioiodinated cells were incubated with Sepharose-Ig, the immunoabsorhant removed 
by centrifugation, and the absorbed samples then treated with saturating amounts of RAMIg +  S. 
aureus.  Aliquots of each eluate were analyzed by SDS-PAGE. Pretreatment with C), Sepharose-anti- 
6; O, Sepharose-anti-TNP; A, Sepharose-anti-Ig. 
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FIG.  2.  Cytotoxicity of rabbit anti-# and alloanti-6 on C57BL/6 and BALB/c splenocytes. Spleen 
cells were washed twice and resuspended in Eagle's minimal essential medium supplemented with 
5% fetal calf serum. To  10  o cells was added dilutions of ailoanti-6, RA# (B6 only), normal mouse 
serum, normal rabbit serum, or medium, bringing the final vol to 0.05 ml per tube. After a 30-45- 
min incubation at 4°C, 0.05 ml of 40-,50% rabbit complement (Pel-Freeze Biologicals, Inc., Rogers, 
Ark.) was added to each sample. Suspensions were incubated at 37°C for 30 min and then assessed 
for the presence of viable and dead cells by trypan blue exclusion. The results are expressed as the 
percent net kill where percent net kill  ,=  100  (dead cells in experimental sample +  [total cells in 
control sample -  total cells in experimental sample])/total cells in control sample -  I00  ×  (dead 
cells in  control sample/total cells in control). O, anti-#;  A, allo-anti-8(C57BL/6J);  O,  allo-anti- 
8(BALB/c). 
of the TD than of the TI response, suggesting that a portion of the cells contributing 
to the TI response express IgM, but little or no IgD. 
Effect of Deleting Cells Bearing IgM or lgD on the Adoptive Antibody Response.  We have 
also  investigated  the  effect  of deleting  IgM  or  IgD-bearing cells  on  the  adoptive 
antibody response to TI and TD antigens. TNP-LPS rather than TNP-BA was used 
as the representative TI antigen because the latter may be TD in vivo. The response 
to TNP-LPS, however, has been shown to be TI both in vivo and in vitro (18,  19). 
The  dose  of TNP-LPS  used  in  these  experiments  was  less  than  that  required  for 
polyclonal activation, i.e.  it induced no increase above background in PFC to either 
HRBC or SRBC at the time of peak response to TNP-LPS. 
As shown in Table II, after deletion of 8 + or #+ cells, the adoptive responses to both 990  L  B  BUCK  ET  AL  BRIEF  DEFINITIVE REPORT 
TABLE  I 
Percent Loss of the Przmary In  Vttro Responses to TNP-BA or TNP-SRBC 
after Treatment of C57BL/ 6 Splenocytes wzth C' and RAI~ and/or Alloantz-8 
Cells treated with C' and 
Exp  anubody against 
Inhibition of responses* 
TNP-BA  TNP-SRBC 
% 
1  8  70  86 
94  91 
6 +  ~  91  99 
Ig  94  --~ 
2  8  65  90 
93  89 
6 +  #  95  94 
Ig  86  85 
3  8  74  50 
#  69  91 
Average  6  70  75 
85  9O 
6  +  ~  93  97 
Ig  90  85 
* The mean response to TNP-BA  m  control cultures was  194  +  65  (SEM) 
PFC per  10  e viable treated cells,  that  to TNP-SRBC was 32  +  11  (SEM) 
PFC per 106 viable treated cells 
:~ Not done 
TNP-SRBC and TNP-LPS in syngeneic hosts were significantly inhibited. Pretreat- 
ment with RA6 appeared to more effectively inhibit both TI and TD responses than 
did treatment with alloanti-6, suggesting that  the latter may be less effective in C'- 
mediated cytolysis. Nevertheless, studies performed with both RA6 and alloanti-6 in 
vivo support  the  conclusions  reached  by  using  alloanti-6  in  the  in  vitro  system, 
namely, that both IgM and IgD are expressed by the majority of cells which respond 
to TI, as well as those which respond to TD, antigens 
Discussion 
The present studies demonstrate that  a  major portion of the in vitro or adoptive 
responses to two TI antigens (TNP-BA and TNP-LPS) are elaborated by cells bearing 
IgM  and  IgD.  Thus,  these  two  responses  were  almost  completely eliminated  by 
treatment with anti-/~ and C' and reduced approximately 70% by treatment with anti- 
6 and C'. 
Previous findings indicated that the in vitro TI response to TNP-BA could not be 
blocked by anti-6 but could be completely abolished by anti-# (5, 6). In contrast, the 
TD response to TNP-SRBC could be blocked by either anti-8 or anti4t (6). The latter 
finding is consistent with the present observation that either anti-6 or anti-~, together 
with C', can  delete the precursors of the TNP-SRBC response. Thus, we conclude 
that  the major precursors of the primary in vitro IgM response to TD antigens are 
/1+6  ÷  and  that  both  receptors  are  required  for  triggering  by  antigen.  The  major 
precursors of the TNP-BA and TNP-LPS responses are also ~+6 + cells, but only the 
IgM receptor is required for triggering by antigen. A possible explananon underlying L.  B.  BUCK ET AL.  BRIEF  DEFINITIVE  REPORT 
TABLE II 
Percent Loss of the tMma~y Adoptive Responses to TNP-LPS and TNP- 
SRBC after Treatment of BDF1 or C57BL/6 Splenocytes with C' and Anti-# 
or Anti-8 
Response  Strain 
TNP-LPS 
TNP-SRBC 
Inhibition of response after treatment 
with C' and antibody directed 
against * 
8,  # 
BDFI  --:~  96 
BDFx  89  83 
C57BL/6  73  -- 
C57BL/6  52  -- 
Average  71  90 
BDF1  96  99 
BDFt  88  -- 
C57BL/6  49  83 
C57BL/6  70  85 
Average  76  85 
* BDFx cells were treated with rabbit anti-8 and C57BL/6 cells were treated 
with alloanti-& The mean response to TNP-LPS was 847:1= 243 (SEM) PFC 
per  l0  T injected cells in BDF1 mice and 2,196 ~  1,061 (SEM) PFC  in 
C57BL/6 mice although the mean response to TNP-SRBC was  19,577 ± 
2309 PFC per  107 injected cells in BDF1 mice and 9,072 ±  714 PFC in 
C57BL/6 mice. 
:~ Not done. 
991 
this latter finding is that antigens that  have an appropriate mitogenic portion may 
bypass the requirement for IgD. This could occur if such antigens bind to both IgM 
and mitogen receptors.  This explanation has  some support  in the literature. Thus, 
TNP-Ficoll, a partially TI antigen (20) which is relatively nonmitogenic,  requires IgD 
on its precursor cells for triggering (5).  In addition, Forni and Coutinho (21)  have 
recently demonstrated a  physical association between IgD and LPS receptors on the 
B-cell surface. It is possible, therefore, that binding of antigen to IgM and either IgD 
or the LPS receptor can deliver a  triggering signal to the B-cell precursor. 
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